How should I evaluate and manage a patient with an elevated white blood cell count and eosinophilia?

Evaluation and Management of Elevated WBC with Eosinophilia

In patients with elevated white blood cell count and eosinophilia (>0.5 × 10⁹/L), immediately determine the absolute eosinophil count (AEC) and assess for end-organ damage, as this dictates urgency and directs your diagnostic pathway toward helminth infections in travelers/migrants, atopic diseases in general populations, or rare but serious conditions like hypereosinophilic syndrome (HES) and eosinophilic granulomatosis with polyangiitis (EGPA). 1

Initial Risk Stratification

Calculate Absolute Eosinophil Count

• Mild eosinophilia: 0.5-1.5 × 10⁹/L (500-1,500 cells/μL)
• Moderate eosinophilia: 1.5-5.0 × 10⁹/L (1,500-5,000 cells/μL)
• Severe eosinophilia: ≥5.0 × 10⁹/L (≥5,000 cells/μL)

Critical action: Any patient with evidence of end-organ damage (cardiac, pulmonary, or neurologic involvement) requires urgent medical assessment and emergency treatment consideration, regardless of eosinophil level 1.

Assess for End-Organ Damage

Look specifically for:

• Cardiac: Myocarditis, conduction disturbances, endomyocardial fibrosis
• Pulmonary: Infiltrates, nodules, pleural effusion
• Neurologic: Encephalitis, myelitis, peripheral neuropathy
• Dermatologic: Urticarial rash, purpura

Diagnostic Algorithm Based on Clinical Context

For Travelers/Migrants (Most Important Context)

Helminth infections are the most common identifiable cause (19-80% of cases) and must be ruled out first 1.

Key Historical Elements:

• Travel history: Specific regions visited (Africa for schistosomiasis, endemic areas for strongyloidiasis)
• Freshwater exposure: Swimming in African freshwater 2-8 weeks prior suggests acute schistosomiasis (Katayama syndrome)
• Timing: Onset relative to travel or new exposures
• Symptoms: Fever, rash, GI symptoms, cough, lymphadenopathy

First-Line Testing for Asymptomatic Eosinophilia:

1. Concentrated stool microscopy (3 samples) or fecal PCR
2. Strongyloides serology (critical - has good diagnostic yield worldwide and concentrated stool has lower sensitivity for Strongyloides)
3. Filarial serology (only if travel to/residence in West Africa)
4. HIV testing per BHIVA guidelines 1

Important caveat: Helminth infection is frequently asymptomatic, and serology/stool microscopy may be negative in early infection (e.g., acute schistosomiasis) 1.

Empirical Treatment Approach:

For asymptomatic eosinophilia with negative stool microscopy in patients >24 months:

• Albendazole 400 mg single dose PLUS
• Ivermectin 200 μg/kg single dose
• Critical warning: Exclude Loa loa before giving ivermectin in patients from endemic regions 1

For suspected schistosomiasis: Repeat treatment at 8 weeks to treat residual worms once they mature to adults 1.

For General Population (No Travel History)

Atopic diseases are the most common cause (53.4% of cases), but hypereosinophilia (≥1.5 × 10⁹/L) is rarely explained by allergy alone and demands further workup 2, 3.

Systematic Evaluation:

1. Medication Review

• Drugs are a common non-infectious cause
• Temporal relationship between medication initiation and eosinophilia onset is key
• Consider stopping suspect medications if safe to do so

2. Atopic Disease Assessment

• Asthma, eczema, allergic rhinitis
• Note: These typically cause mild eosinophilia; if AEC ≥1.5 × 10⁹/L, investigate further 3

3. Screen for Specific Eosinophilic Conditions:

Red flags requiring specialist referral 4:

• BEC ≥10% of total WBC or ≥1,000 cells/μL
• Persistent hypereosinophilia despite treatment
• Refractory asthma requiring prolonged/recurrent systemic corticosteroids
• Extra-pulmonary findings with eosinophilia
• Multiorgan system involvement
• Progressive symptoms over weeks to months

Specific Diagnoses to Consider:

EGPA (Eosinophilic Granulomatosis with Polyangiitis):

• Classic triad: Asthma + eosinophilia + vasculitis
• ANCA testing: 30-40% are ANCA-positive (mostly MPO-ANCA/P-ANCA)
• MPO-ANCA positivity associated with: peripheral neuropathy, renal involvement, purpura
• ANCA-negative patients: higher cardiac involvement, worse overall survival 5
• Remission defined as BVAS = 0 on ≤7.5 mg prednisone daily 5

Allergic Bronchopulmonary Aspergillosis (ABPA):

• Found in 11.6% of eosinophilia cases in tertiary centers
• Consider in patients with asthma and pulmonary infiltrates 2

Hypereosinophilic Syndrome (HES):

• AEC ≥1.5 × 10⁹/L for >6 months with end-organ damage
• Exclude secondary causes first
• Molecular testing: Check for FIP1L1-PDGFRA, PDGFRB mutations (myeloid variant HES) 2
• If persistent eosinophilia ≥1.5 × 10⁹/L for >3 months without end-organ damage after excluding/treating infections: refer to hematology 1

Acute Eosinophilic Pneumonia:

• Febrile illness + diffuse pulmonary infiltrates + pulmonary eosinophilia
• Diagnostic: BAL fluid with ≥40% eosinophils
• Can mimic malignancy or community-acquired pneumonia in elderly 6
• Responds rapidly to corticosteroids

Management Priorities

Immediate Actions for Severe Cases:

• Assess and treat end-organ damage
• Consider corticosteroids for acute presentations with organ involvement
• Seek expert consultation for complex cases

Follow-up for Persistent Eosinophilia:

• If eosinophilia ≥1.5 × 10⁹/L persists >3 months after excluding/treating infectious causes: hematology referral 1
• Monitor for development of end-organ damage
• Screen for cardiovascular comorbidities and treatment-related complications 5

When Etiology Remains Unclear:

• Approximately 19.8% of cases remain without identified cause 2
• This may represent idiopathic hypereosinophilia or idiopathic hypereosinophilic syndrome (if end-organ damage present) 1
• Requires ongoing monitoring and multidisciplinary input

Common Pitfalls to Avoid

1. Assuming allergy explains hypereosinophilia: AEC ≥1.5 × 10⁹/L is rarely from allergy alone 3
2. Missing Strongyloides: Standard stool microscopy has lower sensitivity; always order serology 1
3. Giving ivermectin without excluding Loa loa: Can cause severe complications 1
4. Overlooking cardiac involvement: Eosinophils can cause irreversible cardiac damage 7
5. Delaying treatment in acute schistosomiasis: Empirical treatment justified with compatible history even if serology/microscopy negative 1